Home › Funds › Two Sigma Investments › ENGN
Two Sigma Investments position in ENGN
ENGENE THERAPEUTICS INC · Health Care
Latest position (Q2 2026)164.57K sh
Reported value held$284.71K
Portfolio Weight0.00%
First reportedQ3 2024
Last changeAdd
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2024 | 39.62K | $261.50K | New |
| Q4 2024 | 35.87K | $238.51K | Reduce |
| Q1 2025 | 15.83K | $70.93K | Reduce |
| Q1 2025 | 15.83K | $70.93K | Reduce |
| Q4 2025 | 161.51K | $1.46M | New |
| Q1 2026 | 159.07K | $1.08M | Reduce |
| Q2 2026 | 164.57K | $284.71K | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding ENGN
- Balyasny Asset Management 1.01M sh · $1.74M · Q2 2026
- Renaissance Technologies 829.70K sh · $1.44M · Q2 2026
- UBS Group AG 509.09K sh · $880.72K · Q2 2026
- Morgan Stanley 33.09K sh · $57.24K · Q2 2026
- Citadel Advisors 30.80K sh · $53.28K · Q2 2026
- D. E. Shaw & Co 104.62K sh · $30.33K · Q2 2026
- Point72 Asset Management 13.99K sh · $24.21K · Q2 2026
- Millennium Management 69.00K sh · $20.00K · Q2 2026
- Wells Fargo & Co 6.84K sh · $11.83K · Q2 2026